期刊文献+

Modification of oligonucleotides by isonucleosides incorporation and peptides conjugation

异核苷掺入和肽缀合修饰的寡核苷酸(英文)
原文传递
导出
摘要 Synthetic oligonucleotides including antisense oligonucleotides and siRNA have shown promising therapeutic potential.However,to realize the therapeutic potential of synthetic oligonucleotides,many obstacles have to be overcome,such as their poor biological stability,non-specific activity and inadequate cell membrane permeability.In this paper,the achievements by Lihe Zhang's group in the study of isonucleotide modified oligonucleotides and oligonucleotides conjugated with cell penetrating peptides are summarized. 人工合成的寡核苷酸, 包括反义寡核苷酸、干扰RNA等, 显示了优异的临床潜在应用价值。但要实现合成的寡核苷酸的广泛临床应用, 必须要克服一些障碍性问题, 如该类结构的不稳定性、非特异性作用及难以跨膜吸收等。本文综述了张礼和院士课题组在异核苷掺入及肽缀合寡核苷酸方面的研究成果。
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS 2012年第6期499-508,共10页 中国药学(英文版)
基金 National Natural Science Foundation (Grant No.20932001) the Ministry of Science and Technology (Grant No.2012CB720604)
关键词 Synthetic oligonucleotide Isonucleoside Cell penetrating peptide SIRNA 人工合成寡核苷酸 异核苷 透膜肽 干扰RNA
  • 相关文献

参考文献42

  • 1Zamecnik, P.C.; Stephenson, M.L. Proc. Natl. Acad. Sci. USA. 1978, 75, 280-284.
  • 2Brantl, S. Biochim. Biophys. Acta. 2002, 1575, 15-25.
  • 3Opalinska, J.B.; Gewirtz, A.M. Nat. Rev. Drug Discov. 2002, 1,503-514.
  • 4Bell, N.M.; Micklefield, J. ChemBioChem. 2009, 10, 2691- 2703.
  • 5Pecot, C.V.; Calin, G.A.; Coleman, R.L.; Lopez-Berestein, G.; Sood, A.K. Nat. Rev. Cancer. 2011, 11, 59-67.
  • 6Kuwahara, M.; Sugimoto, N. Molecules. 2010, 15, 5423- 5444.
  • 7Gaglione, M.; Messere, A. Mini Rev. Med. Chem. 2010, 10, 578-595.
  • 8Montgomery, J.A., Thomas, H.J.J. Org. Chem. 1978, 43, 541-544.
  • 9Nair, V.; Jahnke, T.S. Antimicrob. Agents Chemother. 1995, 39, 1017-1029.
  • 10] Yu, H.W.; Zhang, L.R.; Zhou, J.C.; Ma, L.T.; Zhang, L.H. Bioorg. Med. Chem. 1996, 4, 60914.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部